As of Q4'25, Johnson & Johnson's gross margin stands at 67.6%, with an operating margin of 22.1% and a net profit margin of 20.8%. These latest figures indicate a stable profitability profile for the company at the end of the observed period. From Q1'23 to Q4'25, the gross margin has remained robust, generally fluctuating between 66% and 75%, peaking in Q4'23 before normalizing. Operating margin exhibited some volatility, dropping sharply in Q4'23 and Q4'24 but recovering in subsequent quarters. Net profit margin was highly volatile, with a notable spike to 121.9% in Q3'23—likely due to a one-off event—before stabilizing in the 15% to 23% range in 2024 and 2025. Overall, while there were short-term fluctuations, the underlying trend suggests resilient and improving profitability across all margin metrics over the covered period.